TRAF4 Antibodies

Santa Cruz Biotechnology offers a broad range of TRAF4 monoclonal antibodies for research focused on understanding TRAF4's role in various cellular processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TRAF4, or TNF Receptor-Associated Factor 4, functions as a crucial adaptor protein in signaling pathways that regulate immune responses and cell survival. TRAF4 plays a significant role in the activation of NF-κB and MAPK pathways, influencing inflammation and cellular proliferation. Research has shown that TRAF4 expression levels can vary significantly across different tissue types and developmental stages. Understanding TRAF4 function is essential for elucidating its contributions to various diseases, including cancer and autoimmune disorders. TRAF4 has been found to interact with multiple binding partners, contributing to diverse cellular functions. Ongoing studies continue to reveal new aspects of TRAF4's biological significance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of TRAF4's role in human health and disease.